首页 | 本学科首页   官方微博 | 高级检索  
     

细丝蛋白A在宫颈癌患者癌组织中的表达及其临床意义
引用本文:刘秀花,王满,董欣洁,刘京男,韩薇,关英慧. 细丝蛋白A在宫颈癌患者癌组织中的表达及其临床意义[J]. 吉林大学学报(医学版), 2019, 45(6): 1238-1242. DOI: 10.13481/j.1671-587x.20190608
作者姓名:刘秀花  王满  董欣洁  刘京男  韩薇  关英慧
作者单位:吉林大学第一医院二部呼吸科,吉林长春,130031;吉林大学第一医院二部病理科,吉林长春,130031;吉林大学第一医院肿瘤中心,吉林长春,130021
基金项目:国家自然科学基金青年基金资助课题(81702589);吉林大学第一医院二部科研专项基金资助课题(B16)
摘    要:目的:探讨宫颈癌组织中细丝蛋白A (FLNa)的表达及其与宫颈癌患者临床病理学特征的关系,分析FLNa表达与判断预后指标的关联性,阐明FLNa作为评价宫颈癌预后指标的可行性,为临床早期评估宫颈癌预后提供依据。方法:采用免疫组织化学法检测55例宫颈癌组织和癌旁组织中FLNa阳性表达率,RT-PCR法检测20例宫颈癌组织和癌旁组织中FLNa mRNA表达水平,分析FLNa表达与宫颈癌患者临床病理参数的关系。结果:免疫组织化学检测,FLNa定位于细胞质,基底细胞中FLNa表达阳性率高,细胞间质也有部分表达。FLNa在宫颈癌组织中高表达,在癌旁正常组织中不表达。Ⅰ+Ⅱ期宫颈癌患者宫颈癌组织中FLNa阳性表达率低于Ⅲ+Ⅳ期患者(P<0.05)。宫颈癌患者癌组织中FLNa表达与患者TNM分期、淋巴结转移和子宫旁浸润有关联(P<0.05)。RT-PCR检测,在20例宫颈癌组织中FLNa mRNA表达水平高于癌旁正常组织(P<0.05)。结论:FLNa可能成为1项评估宫颈癌患者预后的指标。

关 键 词:宫颈肿瘤  细丝蛋白A  预后  免疫组织化学
收稿时间:2019-01-17

Expression of filamin A in cancer tissue of cervical cancer patients and its clinical significance
LIU Xiuhua,WANG Man,DONG Xinjie,LIU Jingnan,HAN Wei,GUAN Yinghui. Expression of filamin A in cancer tissue of cervical cancer patients and its clinical significance[J]. Journal of Jilin University: Med Ed, 2019, 45(6): 1238-1242. DOI: 10.13481/j.1671-587x.20190608
Authors:LIU Xiuhua  WANG Man  DONG Xinjie  LIU Jingnan  HAN Wei  GUAN Yinghui
Affiliation:1. Department of Respiratory Medicine, First Hospital, Jilin University, Changchun 130031, China;2. Department of Pathology, First Hospital, Jilin University, Changchun 130031, China;3. Tumor Center, First Hospital, Jilin University, Changchun 130021, China
Abstract:Objective: To investigate the expression of filamin A (FLNa) in cervical cancer tissue and its relationships with the clinicopathological characteristics of the cervical cancer patients, to analyze the correlations between the expression of FLNa and the prognostic indicators, to clarify the feasibility of FLNa as a prognostic indicator for cervical cancer,and to provide the evidence for early clinical evaluation on the prognosis of cervical cancer. Methods: The positive expression rates of FLNa in 55 cases of cervical cancer tissue and adjacent tissue were detected by immunohistochemical method,the expression levels of FLNa mRNA in 20 cases of cervical cancer and adjacent tissues were detected by RT-PCR method, and the relationships between the expression of FLNa and the clinicopathological parameters of the patients with cervical cancer were analyzed. Results: The immunohistochemical results showed that FLNa was localized in the cytoplasm,the positive expression rate of FLNa in the basal cells was high and it expressed partly in the interstitium.FLNa highly expressed in the cervical cancer tissue and did not express in the adjacent normal tissue.The positive expression rate of FLNa in the patients with stage Ⅰ+Ⅱ cervical cancer was lower than that in the patients with stage Ⅲ+Ⅳ cervical cancer (P<0.05).The expression of FLNa in cancer tissue of the patients with cervical cancer was associated with TNM stage,lymph node metastasis and parametrial invasion (P<0.05).The RT-PCR results showed that the expression level of FLNa in 20 cases of cervical cancer tissue was higher than that in adjacent normal tissue (P<0.05). Conclusion: FLNa may become a indicator of evaluation on the prognosis of the patients with cervical cancer.
Keywords:cervical cancer  filamin A  prognosis  immunohistochemistry  
本文献已被 万方数据 等数据库收录!
点击此处可从《吉林大学学报(医学版)》浏览原始摘要信息
点击此处可从《吉林大学学报(医学版)》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号